Trial Profile
Determination of rifaximin treatment period according to lactulose breath test values in non-constipated irritable bowel syndrome subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Dec 2015
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 04 Dec 2015 New trial record